Dechra Pharmaceuticals PLCDPH:LSE

987.00
2.00 / 0.20%
24.35k
42.12%
0.2229
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Jul 27 2015 16:36 BST.

Summary

On Monday, Dechra Pharmaceuticals PLC (DPH:LSE) closed at 987.00, 7.58 % below its 52-week high of 1,068, set on May 18, 2015.

52-week range
Today
680.50
Aug 07 2014
1,068
May 18 2015
Markit short selling activity
Low
Medium
High
Open976.50
Day high--
Day low--
Bid--
Offer--
Previous close987.00
Average volume28.02k
Shares outstanding87.97m
Free float85.32m
P/E (TTM)39.12
Market cap866.52m GBP
EPS (TTM)0.2518 GBP
Annual div (IAD)15.77 GBX
Annual div yield (IAD)1.60%
Div ex-dateMar 12 2015
Div pay-dateApr 07 2015
Data delayed at least 15 minutes, as of Jul 27 2015 16:36 BST.
Last IC View
The last IC recommendation on Dechra Pharmaceuticals PLC shares was Hold at 925.00 on 24 Feb 2015
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Dechra Pharmaceuticals PLC-3.05 %-1.40 %+16.67 %+42.12 %+176.18 %
FTSE 100 IDX-4.18 %-3.68 %-5.07 %-4.22 %+21.24 %
Data delayed at least 15 minutes, as of Jul 27 2015 16:36 BST.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.